LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - Enanta Pharmaceuticals (NASDAQ: ENTA)

Follow NASDAQ:ENTA Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ENTA Enanta Pharmaceuticals
Capps Kathleen S. / officer: See Remarks
12/05/2025
Sell
$14.23
323
$5K
8,377
NASDAQ ENTA Enanta Pharmaceuticals
Trout Harry R. III / officer: See Remarks
12/05/2025
Sell
$14.23
542
$8K
16,348
NASDAQ ENTA Enanta Pharmaceuticals
Rottinghaus Scott T. / officer: Chief Medical Officer
12/05/2025
Sell
$14.23
798
$11K
21,792
NASDAQ ENTA Enanta Pharmaceuticals
Luu Brendan / officer: Chief Business Officer
12/05/2025
Sell
$14.23
1,394
$20K
38,329
NASDAQ ENTA Enanta Pharmaceuticals
Kieffer Tara Lynn / officer: Chief Product Strategy Officer
12/05/2025
Sell
$14.23
2,106
$30K
30,620
NASDAQ ENTA Enanta Pharmaceuticals
Or Yat Sun / officer: Chief Scientific Officer
12/05/2025
Sell
$14.23
2,390
$34K
371,392
NASDAQ ENTA Enanta Pharmaceuticals
Luly Jay R. / director, officer: President and CEO
12/05/2025
Sell
$14.23
4,743
$67K
858,026
NASDAQ ENTA Enanta Pharmaceuticals
Capps Kathleen S. / officer: See Remarks
12/01/2025
Sell
$14.12
85
$1K
8,907
NASDAQ ENTA Enanta Pharmaceuticals
Capps Kathleen S. / officer: See Remarks
12/02/2025
Sell
$13.96
207
$3K
8,700
NASDAQ ENTA Enanta Pharmaceuticals
Trout Harry R. III / officer: See Remarks
12/01/2025
Sell
$14.12
105
$1K
17,270
NASDAQ ENTA Enanta Pharmaceuticals
Trout Harry R. III / officer: See Remarks
12/02/2025
Sell
$13.96
380
$5K
16,890
NASDAQ ENTA Enanta Pharmaceuticals
Luu Brendan / officer: Chief Business Officer
12/01/2025
Sell
$14.12
498
$7K
39,723
NASDAQ ENTA Enanta Pharmaceuticals
Kieffer Tara Lynn / officer: Chief Product Strategy Officer
12/01/2025
Sell
$14.12
753
$11K
32,726
NASDAQ ENTA Enanta Pharmaceuticals
Or Yat Sun / officer: Chief Scientific Officer
12/01/2025
Sell
$14.12
753
$11K
373,782
NASDAQ ENTA Enanta Pharmaceuticals
Luly Jay R. / director, officer: President and CEO
12/01/2025
Sell
$14.12
1,885
$27K
862,769
NASDAQ ENTA Enanta Pharmaceuticals
Capps Kathleen S. / officer: See Remarks
11/25/2025
Buy
$13.66
6,325
$86K
6,325
NASDAQ ENTA Enanta Pharmaceuticals
Trout Harry R. III / officer: See Remarks
11/25/2025
Buy
$13.66
12,925
$177K
12,925
NASDAQ ENTA Enanta Pharmaceuticals
Luu Brendan / officer: Chief Business Officer
11/25/2025
Buy
$13.66
90,000
$1.229M
90,000
NASDAQ ENTA Enanta Pharmaceuticals
Kieffer Tara Lynn / officer: Chief Product Strategy Officer
11/25/2025
Buy
$13.66
100,000
$1.366M
100,000
NASDAQ ENTA Enanta Pharmaceuticals
Kowalsky Matthew Paul / officer: Chief Legal Officer
11/25/2025
Buy
$13.66
90,000
$1.229M
90,000
NASDAQ ENTA Enanta Pharmaceuticals
Rottinghaus Scott T. / officer: Chief Medical Officer
11/25/2025
Buy
$13.66
110,000
$1.503M
110,000
NASDAQ ENTA Enanta Pharmaceuticals
Or Yat Sun / officer: Chief Scientific Officer
11/25/2025
Buy
$13.66
110,000
$1.503M
110,000
NASDAQ ENTA Enanta Pharmaceuticals
Luly Jay R. / director, officer: President and CEO
11/25/2025
Buy
$13.66
310,000
$4.235M
310,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous